Imidazolium salts are found to bind abnormally via C5 to iridium(I) and iridium(III) to give air-stable monodentate N-heterocyclic carbene complexes. Abnormal ligand binding was verified by X-ray diffraction in both Ir(I) and Ir(III) complexes. In the case of Ir(I), it is necessary to block the C2 and C4 positions to form a stable sterically protected C5-bound complex. Infrared spectroscopy on carbonyl derivatives indicates that abnormally bound N-heterocyclic carbenes are much stronger electron donors than their ubiquitous C2-bound counterparts. The Tolman electronic parameter for 1-isopropyl-2,4-diphenyl-3-methylimidazolin-5-ylidene is 2039 cm-1, compared to ca. 2050 cm-1 for typical NHCs.

2-Pyridylmethylimidazolium salts and IrH5(PPh3)2 give an [(N-C)IrH2(PPh3)2]+ species with the imidazole ring bound in the 'wrong way': at C-5, not at the expected C-2.

We show that imidazolium salts do not always give normal or even aromatic carbenes on metalation, and the chemistry of these ligands can be much more complicated than previously thought. N,N'-disubstituted imidazolium salts of type [(2-py)(CH(2))(n)(C(3)H(3)N(2))R]BF(4) react with IrH(5)(PPh(3))(2) to give N,C-chelated products (n = 0, 1; 2-py = 2-pyridyl; C(3)H(3)N(2) = imidazolium; R = mesityl, n-butyl, i-propyl, methyl). Depending on the circumstances, three types of kinetic products can be formed: in one, the imidazole metalation site is the normal C2 as expected; in another, the metalation occurs at the abnormal C4 site; and in the third, C4 metalation is accompanied by hydrogenation of the imidazolium ring. The bonding mode is confirmed by structural studies, and spectroscopic criteria can also distinguish the cases. Initial hydrogen transfer can take place from the metal to the carbene to give the imidazolium ring hydrogenation product, as shown by isotope labeling; this hydrogen transfer proves reversible on reflux when the abnormal aromatic carbene is obtained as final product. Care may therefore be needed in the future in verifying the structure(s) formed in cases where a catalyst is generated in situ from imidazolium salt and metal precursor.

No abstract

Changing the counteranion along the series Br, BF4, PF6, SbF6 in their ion-paired 2-pyridylmethyl imidazolium salts causes the kinetic reaction products with IrH5(PPh3)2 to switch from chelating N-heterocyclic carbenes (NHCs) having normal C2 (N path) to abnormal C5 binding (AN path). Computational work (DFT) suggests that the AN path involves C-H oxidative addition to Ir(III) to give Ir(V) with little anion dependence. The N path, in contrast, goes by heterolytic C-H activation with proton transfer to the adjacent hydride. The proton that is transferred is accompanied by the counteranion in an anion-coupled proton transfer, leading to an anion dependence of the N path, and therefore of the N/AN selectivity. The N path goes via Ir(III), not Ir(V), because the normal NHC is a much less strong donor ligand than the abnormal NHC. PGSE NMR experiments support the formation of ion-pair in both the reactants and the products. 19F,1H-HOESY NMR experiments indicate an ion-pair structure for the products that is consistent with the computational prediction (ONIOM(B3PW91/UFF)).